SCHEMBL14048610

SCHEMBL14048610

Fc1ccc(Nc2ccccc2)c2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.65
KMT2A Q03164 6/20 0.65
GAA P10253 5/20 0.65
MAPT P10636 5/20 0.65
TDP1 Q9NUW8 4/20 0.65
KDM4E B2RXH2 4/20 0.65
GLA P06280 2/20 0.65
RECQL P46063 1/20 0.65
ALDH1A1 P00352 8/20 0.53
CDC25B P30305 5/20 0.53
HPGD P15428 3/20 0.53
HSD17B10 Q99714 3/20 0.53
ALOX15 P16050 3/20 0.53
ATM Q13315 2/20 0.53
TSHR P16473 2/20 0.53
CYP3A4 P08684 2/20 0.53
TP53 P04637 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.49
POLB P06746 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5006940 0.88 MAPT (0.50) MEN1KMT2AGAAMAPTTDP1
SCHEMBL11962221 0.87 GAA (0.85) MEN1KMT2AGAAMAPTTDP1
Hydrochloric Acid SCHEMBL4594657 0.86 MAPT (0.48) MEN1KMT2AGAAMAPTTDP1
SCHEMBL25167315 0.85 ADRA2A (0.56) MEN1KMT2AGAAMAPTTDP1
SCHEMBL4741357 0.82 FADS1 (0.66) MEN1KMT2AGAAMAPTTDP1
SCHEMBL4594993 0.81 KDM1A (0.49) MEN1KMT2AGAAMAPTTDP1
SCHEMBL30997736 0.80 MEN1 (0.74) MEN1KMT2AGAAMAPTTDP1
SCHEMBL11883944 0.80 MEN1 (0.74) MEN1KMT2AGAAMAPTTDP1
SCHEMBL6404861 0.80 MEN1 (1.00) MEN1KMT2AGAAMAPTTDP1
SCHEMBL30252201 0.80 MEN1 (0.55) MEN1KMT2AGAAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation APP, BACE1, SNCA MEN1 2044/4885KMT2A 4688/4885GAA 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.